• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The 6-Minute Walk Test and Person-Reported Outcomes in Boys with Duchenne Muscular Dystrophy and Typically Developing Controls: Longitudinal Comparisons and Clinically-Meaningful Changes Over One Year.杜兴氏肌肉营养不良男孩与正常发育对照的6分钟步行测试及患者报告结局:纵向比较及一年期间具有临床意义的变化
PLoS Curr. 2013 Jul 8;5:ecurrents.md.9e17658b007eb79fcd6f723089f79e06. doi: 10.1371/currents.md.9e17658b007eb79fcd6f723089f79e06.
2
The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study.6 分钟步行试验和其他杜氏肌营养不良症的临床终点:来自多中心研究的可靠性、相关性和最小临床重要差异。
Muscle Nerve. 2013 Sep;48(3):357-68. doi: 10.1002/mus.23905. Epub 2013 Jul 17.
3
The 6 minute walk test and performance of upper limb in ambulant duchenne muscular dystrophy boys.6分钟步行试验与杜氏肌营养不良症男孩上肢运动能力
PLoS Curr. 2014 Oct 7;6:ecurrents.md.a93d9904d57dcb08936f2ea89bca6fe6. doi: 10.1371/currents.md.a93d9904d57dcb08936f2ea89bca6fe6.
4
Percent-predicted 6-minute walk distance in duchenne muscular dystrophy to account for maturational influences.杜氏肌营养不良症中考虑成熟影响因素后的预测百分比6分钟步行距离。
PLoS Curr. 2012 Jan 25;4:RRN1297. doi: 10.1371/currents.RRN1297.
5
The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy.6 分钟步行试验作为杜氏肌营养不良症的一种新的疗效评价指标。
Muscle Nerve. 2010 Apr;41(4):500-10. doi: 10.1002/mus.21544.
6
Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy.对杜兴氏肌营养不良症患者通过6分钟步行距离测量的动态功能自然史轨迹进行分类。
Neuromuscul Disord. 2016 Sep;26(9):576-83. doi: 10.1016/j.nmd.2016.05.016. Epub 2016 May 27.
7
Association between neurodevelopmental impairments and motor function in Duchenne muscular dystrophy.Duchenne 型肌营养不良症患儿神经发育损伤与运动功能的相关性研究。
Ann Clin Transl Neurol. 2023 Dec;10(12):2285-2296. doi: 10.1002/acn3.51914. Epub 2023 Oct 7.
8
Individualized Prediction of Changes in 6-Minute Walk Distance for Patients with Duchenne Muscular Dystrophy.杜氏肌营养不良症患者6分钟步行距离变化的个体化预测
PLoS One. 2016 Oct 13;11(10):e0164684. doi: 10.1371/journal.pone.0164684. eCollection 2016.
9
Six-minute walk test versus two-minute walk test in children with Duchenne muscular dystrophy: Is more time more information?杜氏肌营养不良症患儿的六分钟步行试验与两分钟步行试验:时间越长信息越多吗?
Eur J Paediatr Neurol. 2015 Nov;19(6):640-6. doi: 10.1016/j.ejpn.2015.08.002. Epub 2015 Aug 20.
10
Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.依特醇治疗无义突变型杜氏肌营养不良症(ACT DMD)患者的疗效:一项多中心、随机、双盲、安慰剂对照的 3 期临床试验。
Lancet. 2017 Sep 23;390(10101):1489-1498. doi: 10.1016/S0140-6736(17)31611-2. Epub 2017 Jul 17.

引用本文的文献

1
Factors associated with lower forced vital capacity in children and adults with Duchenne muscular dystrophy using non-invasive ventilation: a multicenter analysis.使用无创通气的杜氏肌营养不良症儿童和成人中与较低用力肺活量相关的因素:一项多中心分析。
Sleep Breath. 2025 Jan 7;29(1):68. doi: 10.1007/s11325-024-03183-1.
2
Evidentiary basis of the first regulatory qualification of a digital primary efficacy endpoint.首个数字化主要疗效终点监管资格的证据基础。
Sci Rep. 2024 Nov 29;14(1):29681. doi: 10.1038/s41598-024-80177-9.
3
Association between self-reported and objectively assessed physical functioning in the general population.一般人群中自我报告和客观评估的身体功能之间的关联。
Sci Rep. 2024 Jul 14;14(1):16236. doi: 10.1038/s41598-024-64939-z.
4
Meaningful changes in motor function in Duchenne muscular dystrophy (DMD): A multi-center study.Duchenne 型肌营养不良症(DMD)运动功能的有意义变化:一项多中心研究。
PLoS One. 2024 Jul 10;19(7):e0304984. doi: 10.1371/journal.pone.0304984. eCollection 2024.
5
Establishing how much improvement in lung function and distance walked is clinically important for adult patients with Pompe disease.对于成年庞贝病患者,确定肺功能和步行距离的改善程度在临床上有何重要意义。
Eur J Neurol. 2024 May;31(5):e16223. doi: 10.1111/ene.16223. Epub 2024 Feb 20.
6
Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies - Developing Potential Treatments for the Entire Spectrum of Disease.行业指南草案:杜氏肌营养不良症、贝克肌营养不良症和相关肌营养不良症——为整个疾病谱开发潜在的治疗方法。
J Neuromuscul Dis. 2024;11(2):499-523. doi: 10.3233/JND-230219.
7
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability?安步和非安步杜氏肌营养不良症患者 PUL 2.0 结构域的纵向分析:它们如何与功能能力相关变化?
J Neuromuscul Dis. 2023;10(4):567-574. doi: 10.3233/JND-221556.
8
Heart Failure as the Initial Clinical Manifestation of Becker Muscular Dystrophy in an Adult.成年期以心力衰竭为首发表现的 Becker 型肌营养不良
Tex Heart Inst J. 2022 Nov 1;49(6). doi: 10.14503/THIJ-21-7634.
9
Six-Minute Walk as a Measure of Walking Capacity and Endurance in Patients With Pediatric-Onset Multiple Sclerosis.六分钟步行试验作为评估儿童期发病多发性硬化症患者步行能力和耐力的指标。
Neurology. 2022 Nov 7;99(19):e2161-e2170. doi: 10.1212/WNL.0000000000201098.
10
Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.不同剂量皮质类固醇方案对杜氏肌营养不良症男童临床结局的影响:一项随机临床试验。
JAMA. 2022 Apr 19;327(15):1456-1468. doi: 10.1001/jama.2022.4315.

杜兴氏肌肉营养不良男孩与正常发育对照的6分钟步行测试及患者报告结局:纵向比较及一年期间具有临床意义的变化

The 6-Minute Walk Test and Person-Reported Outcomes in Boys with Duchenne Muscular Dystrophy and Typically Developing Controls: Longitudinal Comparisons and Clinically-Meaningful Changes Over One Year.

作者信息

Henricson Erik, Abresch Richard, Han Jay J, Nicorici Alina, Goude Keller Erica, de Bie Evan, McDonald Craig M

机构信息

Department of Physical Medicine and Rehabilitation, University of California, Davis, Sacramento, California, USA.

出版信息

PLoS Curr. 2013 Jul 8;5:ecurrents.md.9e17658b007eb79fcd6f723089f79e06. doi: 10.1371/currents.md.9e17658b007eb79fcd6f723089f79e06.

DOI:10.1371/currents.md.9e17658b007eb79fcd6f723089f79e06
PMID:23867975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3712467/
Abstract

INTRODUCTION

Data is currently lacking anchoring a 30-meter longitudinal change in walking ability by 6-minute walk test (6MWT) in Duchenne muscular dystrophy as a minimal clinically important difference and "clinically meaningful" person-reported outcomes (PROs) at differing levels of ambulatory ability.

METHODS

We describe correlation between measures, 1-year change in measures, and correlation of 1-year changes between measures for the six-minute walk test (6MWT), 10-meter run/walk velocity, PedsQL and POSNA Pediatric Outcomes Data Collection Instrument (PODCI) in 24 4-12 year old. ambulatory DMD and 36 typical controls, and determine if minimal clinically important differences (MCID) of PROs contribute to different estimates of 6-minute walk distance (6MWD) change at differing levels of ability.

RESULTS

PedsQL total and physical function and PODCI global, transfer/mobility and sports/physical function PROs demonstrated significant differences between DMD and controls (p<0.00001). In DMD, 6MWD and 10-meter run/walk velocity were correlated with PODCI domain scores, with the transfer/mobility scale showing the strongest relationship (r=0.79 and r=0.76). In DMD, 6MWD distance and 10-meter run/walk velocity weakly correlated with PedsQL domain scores. In DMD, 6MWD, 10-meter run/walk velocity, and PODCI global and transfer and basic mobility demonstrated significant one-year change and exceeded the amount of change representing MCID. In DMD, 6MWD change highly correlated with change in PODCI global and PODCI transfer/mobility scores (r=0.76 and r=0.93). PODCI global and PODCI transfer/mobility scales provided the best estimates of 6MWT performance. A "meaningful" 4.5 point change in a low PODCI transfer / basic mobility score of 30 to 34.5 was associated with a 5.6m 6MWD change from 150.3 to 155.9m. At PODCI levels closer to normative levels for healthy controls, the change in 6MWD distance associated with a "meaningful" change in PODCI scores was almost 46m.

DISCUSSION

At lower levels of function, smaller increases in 6MWD result in meaningful change in quality of life (QoL) instrument scores. At higher levels of function, larger increases may be necessary to achieve the same QoL change score.

摘要

引言

目前缺乏数据来确定在杜氏肌营养不良症中,6分钟步行试验(6MWT)所测得的步行能力30米纵向变化作为最小临床重要差异以及在不同步行能力水平下具有“临床意义”的患者报告结局(PROs)。

方法

我们描述了24名4至12岁能行走的杜氏肌营养不良症(DMD)患者和36名典型对照者的6分钟步行试验(6MWT)、10米跑/走速度、儿童生活质量量表(PedsQL)和POSNA儿科结局数据收集工具(PODCI)各项测量指标之间的相关性、测量指标的1年变化以及各测量指标1年变化之间的相关性,并确定PROs的最小临床重要差异(MCID)是否有助于在不同能力水平下对6分钟步行距离(6MWD)变化进行不同估计。

结果

DMD患者与对照组在PedsQL总分及身体功能、PODCI总体、转移/活动能力和运动/身体功能PROs方面存在显著差异(p<0.00001)。在DMD患者中,6MWD和10米跑/走速度与PODCI各领域得分相关,其中转移/活动能力量表显示出最强的相关性(r=0.79和r=0.76)。在DMD患者中,6MWD距离和10米跑/走速度与PedsQL各领域得分的相关性较弱。在DMD患者中,6MWD、10米跑/走速度以及PODCI总体、转移和基本活动能力均有显著的1年变化,且超过了代表MCID的变化量。在DMD患者中,6MWD变化与PODCI总体和PODCI转移/活动能力得分变化高度相关(r=0.76和r=0.93)。PODCI总体和PODCI转移/活动能力量表对6MWT表现的估计最佳。PODCI转移/基本活动能力得分从低水平的30分有“意义”地提高4.5分至34.5分,与6MWD从150.3米变化至155.9米的5.6米变化相关。在PODCI水平更接近健康对照者的标准水平时,与PODCI得分“有意义”变化相关的6MWD距离变化近46米。

讨论

在较低功能水平时,6MWD较小的增加会导致生活质量(QoL)工具得分有意义的变化。在较高功能水平时,可能需要更大的增加才能实现相同的QoL变化得分。